Industry Focus

Here’s why activist billionaire investor Carl Icahn is telling Cigna shareholders to vote against its purchase of Express Scripts. Also, what Regeneron Pharmaceuticals and bluebird bio's new deal means for investors.

Direct download: 20180808_IF_Healthcare_Use.mp3
Category:Podcast -- posted at: 3:30pm EST

1